4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-053648
Chief Commercial Officer sold 1,958 shares at an average $553.11 ($1,082,986)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Huntsman Carole Chief Commercial Officer | 2025-11-21 | Sale 10b5-1 | −894 | $550.97 | $492,567 | 11,096 | D |
| Huntsman Carole Chief Commercial Officer | 2025-11-21 | Sale 10b5-1 | −144 | $547.27 | $78,807 | 10,952 | D |
| Huntsman Carole Chief Commercial Officer | 2025-11-21 | Sale 10b5-1 | −120 | $548.71 | $65,845 | 10,832 | D |
| Huntsman Carole Chief Commercial Officer | 2025-11-21 | Sale 10b5-1 | −40 | $549.34 | $21,974 | 10,792 | D |
| Huntsman Carole Chief Commercial Officer | 2025-11-21 | Sale 10b5-1 | −200 | $552.38 | $110,477 | 10,592 | D |
| Huntsman Carole Chief Commercial Officer | 2025-11-21 | Sale 10b5-1 | −40 | $553.23 | $22,129 | 10,552 | D |
| Huntsman Carole Chief Commercial Officer | 2025-11-21 | Sale 10b5-1 | −120 | $556.04 | $66,725 | 10,432 | D |
| Huntsman Carole Chief Commercial Officer | 2025-11-21 | Sale 10b5-1 | −200 | $559.60 | $111,920 | 10,232 | D |
| Huntsman Carole Chief Commercial Officer | 2025-11-21 | Sale 10b5-1 | −80 | $560.62 | $44,850 | 10,152 | D |
| Huntsman Carole Chief Commercial Officer | 2025-11-21 | Sale 10b5-1 | −40 | $563.21 | $22,528 | 10,112 | D |
| Huntsman Carole Chief Commercial Officer | 2025-11-21 | Sale 10b5-1 | −80 | $564.57 | $45,165 | 10,032 | D |
| Open-market sales · 1,958 sh · avg $553.11 · $1,082,986 | |||||||
Loading xslF345X05/wk-form4_1763764773.xml…